Results 241 to 250 of about 84,459 (353)

Rapid‐Onset Drug‐Induced Liver Injury Following Amoxicillin‐Clavulanate: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Drug‐Induced Liver Injury (DILI) is a rare but potentially serious adverse effect of many commonly used medications. DILI is a diagnosis of exclusion and requires a high index of suspicion. Amoxicillin‐Clavulanate (A‐C) is a widely prescribed antibiotic known to be one of the leading causes of idiosyncratic DILI.
Shuvam Khadka   +5 more
wiley   +1 more source

Salivary Oxidative Stress Markers in Behcet's: A Comparative Study of Active and Inactive Diseases

open access: yesHealth Science Reports, Volume 8, Issue 12, December 2025.
ABSTRACT Background and Aims Behçet's disease (BD) is a systemic inflammatory vasculitis characterized by recurrent oral and genital ulcers; ocular and skin lesions; and vascular, gastrointestinal, and neurological involvement. The absence of specific laboratory markers for disease activity poses a significant challenge in managing BD. This study aimed
Majid Alikhani   +4 more
wiley   +1 more source

Targeted Therapy for Idiopathic Inflammatory Myopathy

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 6, December 2025.
ABSTRACT Background Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of autoimmune disorders characterized by chronic muscle inflammation and significant extramuscular involvement. A substantial proportion of patients exhibit refractory or relapsing disease despite conventional immunosuppressive therapies, necessitating the ...
Ruijie Wang   +3 more
wiley   +1 more source

Australian Real‐World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium

open access: yesJGH Open, Volume 9, Issue 12, December 2025.
ABSTRACT Background Ustekinumab is an effective therapy for the management of Crohn's disease. Australia is unique, as ustekinumab can be prescribed as first‐line biologic therapy, and there is high concomitant immunomodulator use. Aim To evaluate the real‐world efficacy and safety of ustekinumab in moderate to severe Crohn's disease.
Yoon‐Kyo An   +29 more
wiley   +1 more source

Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate

open access: yesJEADV Clinical Practice, Volume 4, Issue 5, Page 1182-1185, December 2025.
Capsule Summary We present a case of a 31‐year‐old female with alopecia universalis, psoriasis vulgaris, and psoriatic arthritis, who showed poor response to prior treatments. Following the initiation of a combination therapy with tofacitinib and methotrexate, significant improvements in joint pain and hair regrowth were observed. This case underscores
Jan Nicolai Wagner   +4 more
wiley   +1 more source

Comprehensive Assessment of Reactogenicity and Safety of the Live-Attenuated Chikungunya Vaccine (IXCHIQ<sup>®</sup>). [PDF]

open access: yesVaccines (Basel)
Maurer G   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy